Ginkgo Bioworks Holdings Inc (DNA) Earnings Call Analysis

NYSE · Healthcare · Biotechnology

10/25

Growth 1 Margin 1 Expansion 4 Platform 2 Financial 2

latest quarter score

Earnings Reports

10
Ginkgo Bioworks (DNA) Q1 2026: Revenue Falls 49% as Autonomous Lab Bet Scales to 103 Racks
May 08, 2026
10
Ginkgo Bioworks (DNA) Q4 2025: Cash Burn Cut 55% as Autonomous Lab Focus Reshapes Strategy
February 27, 2026
10
Ginkgo Bioworks (DNA) Q3 2025: Cash Burn Plummets 75% as AI-Driven Automation Takes Center Stage
November 07, 2025
11
Ginkgo Bioworks (DNA) Q2 2025: $250M Cost Takeout Accelerates Tools Pivot and Margin Safety
August 08, 2025
11
Ginkgo Bioworks (DNA) Q1 2025: $205M Cost Takeout Reshapes Path to EBITDA Breakeven
July 06, 2025

Browse all companies